{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:18:59Z","timestamp":1782940739051,"version":"3.54.5"},"reference-count":128,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Rising rates of alcohol use disorder (AUD) combined with increases in alcohol\u2010related liver disease (ALD) and other liver disease have resulted in the need to develop alcohol management strategies at all levels of patient care. For those with pre\u2010existing liver disease, whether ALD or others, attention to alcohol use treatment and abstinence becomes critical to avoiding worsening liver\u2010related consequences. Modalities to help patients reduce or stop alcohol include screening\/brief intervention\/referral to treatment, various therapeutic modalities including cognitive behavioral therapy, motivational enhancement therapy and 12\u2010step facilitation, and alcohol relapse prevention medications. Harm reduction approaches versus total abstinence may be considered, but for those with existing ALD, particularly advanced ALD (cirrhosis or acute alcoholic hepatitis), total abstinence from alcohol is the recommendation, given clear data that ongoing alcohol use worsens mortality and liver\u2010related morbidity. For certain populations, alcohol cessation is even more critically important. For those with hepatitis C or NAFLD, alcohol use accelerates negative liver\u2010related outcomes. In women, alcohol use accelerates liver damage and results in worsened liver\u2010related mortality. Efforts to integrate AUD and liver disease care are urgently needed and can occur at several levels, with establishment of multidisciplinary ALD clinics for fully integrated co\u2010management as an important goal.<\/jats:p>","DOI":"10.1002\/hep.32531","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T02:35:03Z","timestamp":1650249303000},"page":"1006-1021","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":43,"title":["Alcohol use disorder in community management of chronic liver diseases"],"prefix":"10.1097","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-8754","authenticated-orcid":false,"given":"Lorenzo","family":"Leggio","sequence":"first","affiliation":[{"name":"Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Baltimore and Bethesda, Maryland, USA"},{"name":"Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland, USA"},{"name":"Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island, USA"},{"name":"Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA"},{"name":"Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7364-5035","authenticated-orcid":false,"given":"Jessica L.","family":"Mellinger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan, USA"},{"name":"Department of Psychiatry, Michigan Medicine, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"hep32531-bib-0002-20250824","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","article-title":"Prevalence of 12\u2010month alcohol use, high\u2010risk drinking, and DSM\u2010IV alcohol use disorder in the United States, 2001\u20132002 to 2012\u20132013: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"74","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"hep32531-bib-0003-20250824","article-title":"Association of COVID\u201019 with new waiting list registrations and liver transplantation for alcoholic hepatitis in the United States","volume":"4","year":"2021","journal-title":"JAMA Netw Open"},{"key":"hep32531-bib-0004-20250824","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/ADM.0000000000000767","article-title":"Alcohol consumption in response to the COVID\u201019 pandemic in the United States","volume":"15","year":"2021","journal-title":"J Addict Med"},{"key":"hep32531-bib-0005-20250824","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/alcalc\/agab047","article-title":"Inter\u2010hospital escalation\u2010of\u2010care referrals for severe alcohol\u2010related liver disease with recent drinking during the COVID\u201019 pandemic","volume":"57","year":"2022","journal-title":"Alcohol Alcohol"},{"key":"hep32531-bib-0006-20250824","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/hep.32067","article-title":"Impact of COVID\u201019 pandemic on liver transplantation and alcohol\u2010associated liver disease in the USA","volume":"74","year":"2021","journal-title":"Hepatology"},{"key":"hep32531-bib-0007-20250824","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hep.31605","article-title":"Addressing social determinants of liver disease during the COVID\u201019 pandemic and beyond: a call to action","volume":"73","year":"2021","journal-title":"Hepatology"},{"key":"hep32531-bib-0008-20250824","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.7326\/M20-7271","article-title":"Retail alcohol and tobacco sales during COVID\u201019","volume":"174","year":"2021","journal-title":"Ann Intern Med"},{"key":"hep32531-bib-0009-20250824","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/hep4.1747","article-title":"Alcohol\u2010associated liver disease before and after COVID\u201019\u2010an overview and call for ongoing investigation","volume":"5","year":"2021","journal-title":"Hepatol Commun"},{"key":"hep32531-bib-0010-20250824","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/add.15622","article-title":"Changes in drinking days among United States adults during the COVID\u201019 pandemic","volume":"117","year":"2022","journal-title":"Addiction"},{"key":"hep32531-bib-0011-20250824","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep4.1706","article-title":"COVID\u201019 aftershocks on alcohol\u2010associated liver disease: an early cross\u2010sectional report from the U.S. epicenter","volume":"5","year":"2021","journal-title":"Hepatol Commun"},{"key":"hep32531-bib-0012-20250824","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/eurpub\/ckab183","article-title":"Met and unmet need for mental health care before and during the COVID\u201019 pandemic","volume":"32","year":"2022","journal-title":"Eur J Public Health"},{"key":"hep32531-bib-0013-20250824","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/ADM.0000000000000797","article-title":"COVID\u201019 social distancing and online mutual help engagement for alcohol use recovery","volume":"15","year":"2021","journal-title":"J Addict Med"},{"key":"hep32531-bib-0014-20250824","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/hep.29887","article-title":"The high burden of alcoholic cirrhosis in privately insured persons in the United States","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"hep32531-bib-0015-20250824","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study","volume":"362","year":"2018","journal-title":"BMJ"},{"key":"hep32531-bib-0016-20250824","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1016\/S2468-2667(20)30062-1","article-title":"Projected prevalence and mortality associated with alcohol\u2010related liver disease in the USA, 2019\u201340: a modelling study","volume":"5","year":"2020","journal-title":"Lancet Public Health"},{"key":"hep32531-bib-0017-20250824","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamapsychiatry.2021.1271","article-title":"Use of medications for alcohol use disorder in the US: results from the 2019 National Survey on Drug Use and Health","volume":"78","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"hep32531-bib-0018-20250824","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/acer.13944","article-title":"Gender disparities in alcohol use disorder treatment among privately insured patients with alcohol\u2010associated cirrhosis","volume":"43","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0019-20250824","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.31042","article-title":"Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis","volume":"71","year":"2020","journal-title":"Hepatology"},{"key":"hep32531-bib-0020-20250824","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2016.10.004","article-title":"Treatment of alcohol use disorder in patients with alcoholic liver disease","volume":"130","year":"2017","journal-title":"Am J Med"},{"key":"hep32531-bib-0021-20250824","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archinte.165.9.986","article-title":"Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta\u2010analysis","volume":"165","year":"2005","journal-title":"Arch Intern Med"},{"key":"hep32531-bib-0022-20250824","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/alcalc\/agt170","article-title":"The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews","volume":"49","year":"2014","journal-title":"Alcohol Alcohol"},{"key":"hep32531-bib-0023-20250824","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1465-3362.2010.00217.x","article-title":"Alcohol screening and brief intervention in primary care: absence of evidence for efficacy in people with dependence or very heavy drinking","volume":"29","year":"2010","journal-title":"Drug Alcohol Rev"},{"key":"hep32531-bib-0024-20250824","doi-asserted-by":"crossref","first-page":"108179","DOI":"10.1016\/j.jsat.2020.108179","article-title":"The short\u2010term impact on economic outcomes of SBIRT interventions implemented in reproductive health care settings","volume":"120","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"hep32531-bib-0025-20250824","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","year":"2019","journal-title":"Sci Adv"},{"key":"hep32531-bib-0026-20250824","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1046\/j.1360-0443.1998.93913133.x","article-title":"Network support for drinking, Alcoholics Anonymous and long\u2010term matching effects","volume":"93","year":"1998","journal-title":"Addiction"},{"key":"hep32531-bib-0027-20250824","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.addbeh.2018.06.018","article-title":"Expanding the reach of alcohol and other drug services: prevalence and correlates of US adult engagement with online technology to address substance problems","volume":"87","year":"2018","journal-title":"Addict Behav"},{"key":"hep32531-bib-0028-20250824","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/alcalc\/agaa050","article-title":"Alcoholics Anonymous and 12\u2010step facilitation treatments for alcohol use disorder: a distillation of a 2020 Cochrane Review for Clinicians and Policy Makers","volume":"55","year":"2020","journal-title":"Alcohol Alcohol"},{"key":"hep32531-bib-0029-20250824","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1037\/0022-006X.61.3.455","article-title":"Enhancing motivation for change in problem drinking: a controlled comparison of two therapist styles","volume":"61","year":"1993","journal-title":"J Consult Clin Psychol"},{"key":"hep32531-bib-0030-20250824","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S2215-0366(19)30213-5","article-title":"Prevention, screening, and treatment for heavy drinking and alcohol use disorder","volume":"6","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"hep32531-bib-0031-20250824","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/SAR.S138439","article-title":"A review of contingency management for the treatment of substance\u2010use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies","volume":"9","year":"2018","journal-title":"Subst Abuse Rehabil"},{"key":"hep32531-bib-0032-20250824","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/add.12589","article-title":"Prize\u2010based contingency management for the treatment of substance abusers: a meta\u2010analysis","volume":"109","year":"2014","journal-title":"Addiction"},{"key":"hep32531-bib-0033-20250824","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1747-597X-6-17","article-title":"Relapse prevention for addictive behaviors","volume":"6","year":"2011","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"hep32531-bib-0034-20250824","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1037\/ccp0000447","article-title":"A meta\u2010analysis of cognitive\u2010behavioral therapy for alcohol or other drug use disorders: treatment efficacy by contrast condition","volume":"87","year":"2019","journal-title":"J Consult Clin Psychol"},{"key":"hep32531-bib-0035-20250824","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cgh.2015.07.047","article-title":"Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver\u00a0disease: a systematic review","volume":"14","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32531-bib-0036-20250824","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"hep32531-bib-0037-20250824","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta\u2010analysis","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"hep32531-bib-0038-20250824","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1530-0277.2011.01601.x","article-title":"Hepatic safety and antiretroviral effectiveness in HIV\u2010infected patients receiving naltrexone","volume":"36","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0039-20250824","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0168-8278(97)80355-8","article-title":"Effect of liver cirrhosis on the systemic availability of naltrexone in humans","volume":"27","year":"1997","journal-title":"J Hepatol"},{"key":"hep32531-bib-0040-20250824","first-page":"687","article-title":"Effect of acute administration of acamprosate on the risk of encephalopathy and on arterial pressure in patients with alcoholic cirrhosis","volume":"16","year":"1992","journal-title":"Gastroenterol Clin Biol"},{"key":"hep32531-bib-0041-20250824","first-page":"443","article-title":"Medication development for alcohol use disorder: a focus on clinical studies","volume":"258","year":"2020","journal-title":"Handb Exp Pharmacol"},{"key":"hep32531-bib-0042-20250824","first-page":"579","article-title":"Advances in pharmacotherapy development: human clinical studies","volume":"248","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"hep32531-bib-0043-20250824","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/YCO.0000000000000519","article-title":"Prospects for pharmacotherapies to treat alcohol use disorder: an update on recent human studies","volume":"32","year":"2019","journal-title":"Curr Opin Psychiatry"},{"key":"hep32531-bib-0044-20250824","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"hep32531-bib-0045-20250824","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","year":"2007","journal-title":"JAMA"},{"key":"hep32531-bib-0046-20250824","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1176\/appi.ajp.2013.13081014","article-title":"Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism","volume":"171","year":"2014","journal-title":"Am J Psychiatry"},{"key":"hep32531-bib-0047-20250824","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41386-020-00945-9","article-title":"Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder","volume":"46","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"hep32531-bib-0048-20250824","doi-asserted-by":"crossref","first-page":"108762","DOI":"10.1016\/j.drugalcdep.2021.108762","article-title":"Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorder","volume":"225","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"hep32531-bib-0049-20250824","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/alcalc\/agx108","article-title":"Comparing and combining topiramate and aripiprazole on alcohol\u2010related outcomes in a human laboratory study","volume":"53","year":"2018","journal-title":"Alcohol Alcohol"},{"key":"hep32531-bib-0050-20250824","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/adb.12192","article-title":"Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments","volume":"21","year":"2016","journal-title":"Addict Biol"},{"key":"hep32531-bib-0051-20250824","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1001\/archinte.168.11.1188","article-title":"Improvement of physical health and quality of life of alcohol\u2010dependent individuals with topiramate treatment: US multisite randomized controlled trial","volume":"168","year":"2008","journal-title":"Arch Intern Med"},{"key":"hep32531-bib-0053-20250824","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0b013e3181aba6a4","article-title":"Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms","volume":"29","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"hep32531-bib-0054-20250824","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1369-1600.2008.00133.x","article-title":"Proof\u2010of\u2010concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin","volume":"14","year":"2009","journal-title":"Addict Biol"},{"key":"hep32531-bib-0055-20250824","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","year":"2014","journal-title":"JAMA Intern Med"},{"key":"hep32531-bib-0056-20250824","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/acer.13917","article-title":"Gabapentin enacarbil extended\u2010release for alcohol use disorder: a randomized, double\u2010blind, placebo\u2010controlled, multisite trial assessing efficacy and safety","volume":"43","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0057-20250824","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/acer.14414","article-title":"Gabapentin enacarbil extended\u2010release versus placebo: a likely responder reanalysis of a randomized clinical trial","volume":"44","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0058-20250824","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","article-title":"Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial","volume":"180","year":"2020","journal-title":"JAMA Intern Med"},{"key":"hep32531-bib-0059-20250824","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder","volume":"175","year":"2018","journal-title":"Am J Psychiatry"},{"key":"hep32531-bib-0060-20250824","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A double\u2010blind, placebo\u2010controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence","volume":"7","year":"2013","journal-title":"J Addict Med"},{"key":"hep32531-bib-0061-20250824","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self\u2010administration in heavy\u2010drinking smokers","volume":"66","year":"2009","journal-title":"Biol Psychiatry"},{"key":"hep32531-bib-0062-20250824","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00213-012-2717-x","article-title":"Varenicline decreases alcohol consumption in heavy\u2010drinking smokers","volume":"223","year":"2012","journal-title":"Psychopharmacology"},{"key":"hep32531-bib-0063-20250824","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.drugalcdep.2013.06.019","article-title":"Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence","volume":"133","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"hep32531-bib-0064-20250824","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1007\/s00213-014-3518-1","article-title":"Varenicline effects on drinking, craving and neural reward processing among non\u2010treatment\u2010seeking alcohol\u2010dependent individuals","volume":"231","year":"2014","journal-title":"Psychopharmacology"},{"key":"hep32531-bib-0065-20250824","article-title":"Effects of varenicline on neural correlates of alcohol salience in heavy drinkers","volume":"18","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"hep32531-bib-0066-20250824","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00213-014-3742-8","article-title":"Effects of exercise on the desire to smoke and physiological responses to temporary smoking abstinence: a crossover trial","volume":"232","year":"2015","journal-title":"Psychopharmacology"},{"key":"hep32531-bib-0067-20250824","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/acer.14352","article-title":"Effects of alcohol cue reactivity on subsequent treatment outcomes among treatment\u2010seeking individuals with alcohol use disorder: a multisite randomized, double\u2010blind, placebo\u2010controlled clinical trial of varenicline","volume":"44","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0068-20250824","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/acer.12854","article-title":"Varenicline for treatment of alcohol dependence: a randomized, placebo\u2010controlled trial","volume":"39","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0069-20250824","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ADM.0000000000000133","article-title":"Moderators of varenicline treatment effects in a double\u2010blind, placebo\u2010controlled trial for alcohol dependence: an exploratory analysis","volume":"9","year":"2015","journal-title":"J Addict Med"},{"key":"hep32531-bib-0070-20250824","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1176\/appi.ajp.2015.15040567","article-title":"Management of alcohol use disorder in patients requiring liver transplant","volume":"172","year":"2015","journal-title":"Am J Psychiatry"},{"key":"hep32531-bib-0071-20250824","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S2215-0366(18)30303-1","article-title":"Baclofen for the treatment of alcohol use disorder: the Cagliari Statement","volume":"5","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"hep32531-bib-0072-20250824","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41386-021-01055-w","article-title":"Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose\u2010response, randomized, controlled trial","volume":"46","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"hep32531-bib-0073-20250824","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/s41386-021-01142-y","article-title":"The GABA\u2010B receptor agonist baclofen helps patients with alcohol use disorder: why these findings matter","volume":"46","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"hep32531-bib-0074-20250824","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","article-title":"National trends and long\u2010term outcomes of liver transplant for alcohol\u2010associated liver disease in the United States","volume":"179","year":"2019","journal-title":"JAMA Intern Med"},{"key":"hep32531-bib-0075-20250824","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/lt.25681","article-title":"Meeting report: the Dallas consensus conference on liver transplantation for alcohol associated hepatitis","volume":"26","year":"2020","journal-title":"Liver Transpl"},{"key":"hep32531-bib-0076-20250824","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","year":"2018","journal-title":"Gastroenterology"},{"key":"hep32531-bib-0077-20250824","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1600-6143.2010.03232.x","article-title":"Trajectories of alcohol consumption following liver transplantation","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"hep32531-bib-0078-20250824","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ajg.2015.204","article-title":"Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication","volume":"110","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"hep32531-bib-0079-20250824","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/lt.24425","article-title":"Severe alcoholic relapse after liver transplantation: What consequences on the graft? A study based on liver biopsies analysis","volume":"22","year":"2016","journal-title":"Liver Transpl"},{"key":"hep32531-bib-0080-20250824","doi-asserted-by":"crossref","first-page":"551","DOI":"10.14309\/ajg.0000000000001007","article-title":"Excess mortality after liver transplantation in young women with alcohol\u2010associated liver disease","volume":"116","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"hep32531-bib-0081-20250824","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1530-0277.2010.01290.x","article-title":"Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials","volume":"34","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0082-20250824","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/add.15011","article-title":"World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom","volume":"115","year":"2020","journal-title":"Addiction"},{"key":"hep32531-bib-0083-20250824","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2019.03.020","article-title":"Reduction in non\u2010abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3\u2010year follow\u2010up results in the US general population","volume":"201","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"hep32531-bib-0084-20250824","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/acer.13897","article-title":"Drinking risk level reductions associated with improvements in physical health and quality of life among individuals with alcohol use disorder","volume":"42","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0085-20250824","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/adb.12414","article-title":"Harm reduction\u2010a systematic review on effects of alcohol reduction on physical and mental symptoms","volume":"22","year":"2017","journal-title":"Addict Biol"},{"key":"hep32531-bib-0086-20250824","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/acer.13884","article-title":"Reduction in nonabstinent WHO drinking risk levels and change in risk for liver disease and positive AUDIT\u2010C scores: prospective 3\u2010year follow\u2010up results in the U.S. general population","volume":"42","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0087-20250824","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cld.2018.09.004","article-title":"Alcohol use disorders in alcoholic liver disease","volume":"23","year":"2019","journal-title":"Clin Liver Dis"},{"key":"hep32531-bib-0088-20250824","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/j.1572-0241.2008.01837.x","article-title":"Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"hep32531-bib-0089-20250824","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1465-3362.2009.00153.x","article-title":"Alcohol as a risk factor for liver cirrhosis: a systematic review and meta\u2010analysis","volume":"29","year":"2010","journal-title":"Drug Alcohol Rev"},{"key":"hep32531-bib-0090-20250824","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","year":"2017","journal-title":"Hepatology"},{"key":"hep32531-bib-0091-20250824","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"hep32531-bib-0092-20250824","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol\u2010associated liver diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases","volume":"71","year":"2020","journal-title":"Hepatology"},{"key":"hep32531-bib-0093-20250824","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/hep.29631","article-title":"Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep32531-bib-0094-20250824","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510250120","article-title":"Excess weight risk factor for alcoholic liver disease","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"hep32531-bib-0095-20250824","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/jhep.2002.31782","article-title":"Risk factors of fibrosis in alcohol\u2010induced liver disease","volume":"35","year":"2002","journal-title":"Hepatology"},{"key":"hep32531-bib-0096-20250824","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/00365520802555991","article-title":"Alcohol consumption is associated with progression of hepatic fibrosis in non\u2010alcoholic fatty liver disease","volume":"44","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"hep32531-bib-0097-20250824","article-title":"Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study","volume":"340","year":"2010","journal-title":"BMJ"},{"key":"hep32531-bib-0098-20250824","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"hep32531-bib-0099-20250824","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/aje\/kws252","article-title":"Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study","volume":"177","year":"2013","journal-title":"Am J Epidemiol"},{"key":"hep32531-bib-0100-20250824","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jamcollsurg.2010.09.020","article-title":"Impaired alcohol metabolism after gastric bypass surgery: a case\u2010crossover trial","volume":"212","year":"2011","journal-title":"J Am Coll Surg"},{"key":"hep32531-bib-0101-20250824","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1001\/jamasurg.2015.1884","article-title":"Effect of Roux\u2010en\u2010Y gastric bypass surgery: converting 2 alcoholic drinks to 4","volume":"150","year":"2015","journal-title":"JAMA Surg"},{"key":"hep32531-bib-0102-20250824","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.soard.2012.12.010","article-title":"Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient\u20132013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery","volume":"9","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"hep32531-bib-0103-20250824","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.soard.2012.01.016","article-title":"Alcohol and bariatric surgery: review and suggested recommendations for assessment and management","volume":"8","year":"2012","journal-title":"Surg Obes Relat Dis"},{"key":"hep32531-bib-0104-20250824","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s00464-018-6545-x","article-title":"New onset alcohol use disorder following bariatric surgery","volume":"33","year":"2019","journal-title":"Surg Endosc"},{"key":"hep32531-bib-0105-20250824","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/adb.12436","article-title":"The gut in the brain: the effects of bariatric surgery on alcohol consumption","volume":"22","year":"2017","journal-title":"Addict Biol"},{"key":"hep32531-bib-0106-20250824","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/liv.14805","article-title":"Bariatric surgery and the risk of alcohol\u2010related cirrhosis and alcohol misuse","volume":"41","year":"2021","journal-title":"Liver Int"},{"key":"hep32531-bib-0107-20250824","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MCG.0000000000001506","article-title":"Roux\u2010en\u2010Y gastric bypass is associated with increased hazard for de novo alcohol\u2010related complications and liver disease","volume":"56","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"hep32531-bib-0108-20250824","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.14309\/ajg.0000000000000340","article-title":"Alcohol consumption and risk of liver cirrhosis: a systematic review and meta\u2010analysis","volume":"114","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"hep32531-bib-0109-20250824","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1111\/acer.13904","article-title":"Alcohol dehydrogenases, aldehyde dehydrogenases, and alcohol use disorders: a critical review","volume":"42","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0110-20250824","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1530-0277.2001.tb02242.x","article-title":"Gender differences in pharmacokinetics of alcohol","volume":"25","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0111-20250824","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM199001113220205","article-title":"High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first\u2010pass metabolism","volume":"322","year":"1990","journal-title":"N Engl J Med"},{"key":"hep32531-bib-0113-20250824","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1530-0277.2000.tb02005.x","article-title":"Influence of sex hormones on alcohol metabolism","volume":"24","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0114-20250824","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/acer.13965","article-title":"Gender differences in use of alcohol treatment services and reasons for nonuse in a national sample","volume":"43","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0115-20250824","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/acer.12500","article-title":"A moderating role for gender in racial\/ethnic disparities in alcohol services utilization: results from the 2000 to 2010 national alcohol surveys","volume":"38","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0116-20250824","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.03.010","article-title":"Gender and race\/ethnicity differences for initiation of alcohol\u2010related service use among persons with alcohol dependence","volume":"140","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"hep32531-bib-0117-20250824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2010.03.002","article-title":"Barriers and facilitators for alcohol treatment for women: are there more or less for rural women?","volume":"39","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"hep32531-bib-0118-20250824","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1300\/J465v29n01_06","article-title":"The multidimensional structure of external barriers to substance abuse treatment and its invariance across gender, ethnicity, and age","volume":"29","year":"2008","journal-title":"Subst Abus"},{"key":"hep32531-bib-0119-20250824","doi-asserted-by":"crossref","first-page":"329","DOI":"10.14309\/ajg.0000000000000966","article-title":"Alcohol intake and mortality in patients with chronic viral hepatitis: a nationwide cohort study","volume":"116","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"hep32531-bib-0120-20250824","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2015.07.056","article-title":"Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001\u20102013","volume":"149","year":"2015","journal-title":"Gastroenterology"},{"key":"hep32531-bib-0121-20250824","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jhep.2017.10.019","article-title":"The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: an international study","volume":"68","year":"2018","journal-title":"J Hepatol"},{"key":"hep32531-bib-0122-20250824","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/hep.31058","article-title":"A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection","volume":"71","year":"2020","journal-title":"Hepatology"},{"key":"hep32531-bib-0123-20250824","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2016.04.029","article-title":"Treatment of alcohol use disorders in patients with alcoholic liver disease","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"hep32531-bib-0124-20250824","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"hep32531-bib-0125-20250824","article-title":"The multidisciplinary support in preventing alcohol relapse after liver transplantation: a single\u2010center experience","volume":"32","year":"2018","journal-title":"Clin Transplant"},{"key":"hep32531-bib-0126-20250824","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/lt.25641","article-title":"Integration of an addiction team in a liver transplantation center","volume":"25","year":"2019","journal-title":"Liver Transpl"},{"key":"hep32531-bib-0127-20250824","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.psym.2019.12.004","article-title":"Confronting the crisis of comorbid alcohol use disorder and alcohol\u2010related liver disease with a novel multidisciplinary clinic","volume":"61","year":"2020","journal-title":"Psychosomatics"},{"key":"hep32531-bib-0128-20250824","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.cgh.2020.10.026","article-title":"Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American Association for the Study of Liver Diseases Alcohol\u2010Associated Liver Disease Special Interest Group","volume":"19","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32531-bib-0129-20250824","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2468-1253(21)00191-6","article-title":"Barriers to the management of alcohol use disorder and alcohol\u2010associated liver disease: strategies to implement integrated care models","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"hep32531-bib-0130-20250824","article-title":"Integrated care of alcohol\u2010related liver disease","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"hep32531-bib-0131-20250824","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: acoholic liver disease","volume":"113","year":"2018","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.32531","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.32531","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T22:03:25Z","timestamp":1756073005000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":128,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.32531","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"2022-03-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}